查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808578

神经设备市场（按产品、应用、最终用户和分销管道）—2025-2030 年全球预测

Neurology Devices Market by Product, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

神经系统设备市场预计到 2024 年将达到 127.4 亿美元，2025 年将达到 139.6 亿美元，到 2030 年将达到 228 亿美元，复合年增长率为 10.18%。

主要市场统计数据
基准年2024年 127.4亿美元
预计2025年 139.6亿美元
预测年份 2030 228亿美元
复合年增长率（%） 10.18%

探索在技术快速发展和监管变化的时代塑造先进神经病学设备的不断发展的创新和挑战

神经医学医疗设备领域正处于关键的十字路口，技术突破和临床实践的转变正在迅速改变患者的治疗通讯协定。随着精准医疗的发展，设备开发商正在整合先进的感测器、人工智慧和先进材料，以根据患者独特的神经生理特征提供客製化治疗方案。越来越多的临床证据表明，治疗效果得到改善，不利事件减少，进一步推动了个人化治疗的发展。

新兴技术、临床模式转移和跨学科整合如何重新定义神经病学设备开发和患者照护途径

多学科协作和以患者为中心的设计理念正在推动一波变革，重塑神经病学设备格局。神经影像学和术中导航的快速发展使微创手术成为新的治疗标准，缩短了手术时间并加快了患者康復。同时，植入式神经调节系统的广泛应用正在重新定义从慢性疼痛到神经退化性疾病等各种疾病的治疗模式，其封闭回路型回馈机制提高了疗效和安全性。

评估 2025 年美国关税对神经医学医疗设备供应链、成本结构和竞争动态的整体影响

2025年美国关税的实施为神经病学设备生态系统带来了巨大的阻力，影响了价值链的各个环节。面对进口零件关税的提高，製造商必须重新评估筹资策略，一些製造商将部分生产转移到更靠近终端市场的地方，以减轻成本影响。虽然这种向近岸外包的转变降低了供应链的脆弱性，但也需要对国内基础设施进行大量的资本投资。

发现产品、应用、最终用户和分销管道的关键细分模式，以推动策略性神经医学医疗设备决策

关键细分市场分析揭示了推动应用和投资的细微驱动因素，并突显了临床和商业重点的交会点。评估产品格局表明，涵盖脑脊髓液管理设备（例如神经外科引流和脑分流术）以及介入性神经病学工具（包括动脉瘤栓塞和栓塞术、球囊血管成形术和支架、神经血栓切除术和神经血管导管）的技术各自都呈现出独特的创新需求。动脉瘤栓塞和栓塞术强调了栓塞圈、血流转向装置和液体栓塞剂在降低復发率方面的作用，而脑球囊血管成形术和支架置入术策略则着重于优化球囊闭塞、颈动脉支架和过滤装置的设备配置。同样，神经血栓切除术的演变凸显了血栓移除装置、勒除器器和真空抽吸系统的发展；而神经刺激领域的不断扩展则涵盖了深部脑部刺激、胃电刺激、荐椎神经刺激、脊髓刺激和迷走神经刺激。最后，动脉瘤夹、神经科学用内视镜、立体定位系统和超音波吸引器等神经外科设备的进步，凸显了人们对精准和微创治疗的持续追求。

分析影响美国、欧洲、中东和非洲以及亚太地区神经病学设备采用路径的机会和挑战

区域动态在塑造神经病学设备市场的发展轨迹方面发挥着重要作用，因为多样化的医疗基础设施、报销框架和患者人口统计都会影响采用率。美洲地区凭藉其成熟的学术医疗中心网络和良好的数位疗法法规环境，已迅速普及先进的监测和神经调节系统。然而，成本控制压力以及向基于价值的医疗模式的转变，正在加强对长期临床效益的审查。

分析关键参与者和创新者，以发现神经医学医疗设备领域的策略联盟、创新路径和竞争优势

主要企业和新兴创新者正透过策略联盟、定向研发投入以及整合护理模式的构建，树立新的标竿。老字型大小企业正在深化与学术中心的合作，共同开发融合先进感测和自适应演算法的下一代神经刺激平台。同时，新创公司正在开拓生物电子学和软体机器人技术，展示成功的概念验证，并吸引许可和收购的兴趣。

产业领导者的策略蓝图，旨在应对监管复杂性、利用技术进步并加强其在医疗设备领域的地位

产业领导者必须采取前瞻性策略，使研发重点与不断发展的临床和监管模式保持一致。企业应优先开发能够支援多种适应症的平台技术，以最大限度地提高投资收益并促进跨职能协同效应。对强大的数据分析和远端监控能力的投资将增强真实世界证据的产生。

结合初步访谈、二次资料分析和统计检验的综合研究途径确保对神经病学设备有深入的了解

本研究采用多阶段方法，确保研究结论的完整性和有效性。主要资料收集包括与关键意见领袖（包括神经科、介入放射科医生和设备工程师）进行结构化访谈，以掌握未满足需求和创新瓶颈的第一手观点。次要研究资讯来源包括监管资料库、临床试验註册中心和同行评审文献，以揭示产品平臺和核准趋势。

综合关键发现和策略重点，确定神经医学医疗设备领域的未来方向和投资机会

快速的技术进步、不断变化的报销模式以及日益复杂的监管环境定义了神经医学医疗设备领域的格局。透过分析，我们可以清楚地看到，那些整合数位智慧、深化策略伙伴关係并保持敏捷製造地的公司将会获得成功。透过闭合迴路神经调节和微创干预实现的个人化治疗将推动下一波临床突破。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 用于持续家庭癫痫监测的人工智慧可携式脑电图可穿戴设备的成长和整合
  • 封闭回路型深部脑部刺激装置的进展为巴金森氏症的治疗提供了适应性疗法
  • 非侵入性经颅磁刺激装置在难治性重度忧郁症治疗的应用日益增多
  • 推出可与智慧型手机连接、用于缓解慢性神经病变疼痛的植入式无线神经刺激系统
  • 用于瘫痪復健即时脑机介面控制的高密度皮质内电极阵列的开发
  • 扩展小型可穿戴近红外光谱设备，用于中风復健计画中的非侵入性监测

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章神经系统设备市场（按产品）

  • 脑脊髓液管理装置
    • 脑外引流
    • 脑分流术
  • 介入性神经病学
    • 动脉瘤线圈栓塞术
      • 栓塞线圈
      • 导流装置
      • 液态栓塞试剂
    • 脑球囊血管成形术和支架
      • 球囊封堵器
      • 颈动脉支架
      • 过滤装置
    • 神经血栓切除术
      • 血块回收器
      • 勒除器装置
      • 吸力吸引装置
    • 神经血管导管
  • 神经刺激
    • 深部脑部刺激
    • 胃电刺激
    • 荐椎神经刺激
    • 脊髓刺激
    • 迷走神经刺激
  • 神经外科设备
    • 动脉瘤夹
    • 神经科学用内视镜
    • 立体定位放射系统
    • 超音波吸引器

第九章 神经设备市场（按应用）

  • 慢性疼痛
  • 癫痫和癫痫发作
    • 癫痫的诊断和监测
    • 癫痫抑制装置
  • 精神疾病
    • 焦虑
    • 忧郁症
    • 思觉失调症
  • 多发性硬化症（MS）
  • 神经退化性疾病
    • 阿兹海默症
    • 肌萎缩侧索硬化症（ALS）
    • 亨丁顿舞蹈症
    • 帕金森氏症
  • 神经血管疾病
  • 脊髓损伤
  • 中风
    • 出血性中风装置
    • 缺血性中风设备
    • 中风復健设备
  • 创伤性脑损伤（TBI）

第 10 章 神经设备市场（依最终用户）

  • 学术研究机构
  • 诊断中心
  • 居家护理
  • 医院
  • 神经科诊所
  • 復健中心

第 11 章神经系统设备市场（依通路）

  • 离线
  • 在线的

第 12 章：美洲神经设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：欧洲、中东和非洲的神经设备市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第 14 章：亚太神经设备市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Acandis GmbH
    • B. Braun SE
    • Boston Scientific Corporation
    • Esaote SpA
    • GE HealthCare Technologies, Inc.
    • Integra LifeSciences Holdings
    • Koninklijke Philips NV
    • Masimo Corporation
    • Medtronic PLC
    • MicroPort Scientific Corporation
    • Natus Medical Inc.
    • Nihon Kohden Corporation
    • Penumbra Inc.
    • Rapid Medical Ltd.
    • Siemens Healthcare GmbH
    • Stryker Corporation
    • Terumo Corporation

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-F6513A06BEEC

The Neurology Devices Market was valued at USD 12.74 billion in 2024 and is projected to grow to USD 13.96 billion in 2025, with a CAGR of 10.18%, reaching USD 22.80 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 12.74 billion
Estimated Year [2025] USD 13.96 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 10.18%

Discover the Unfolding Innovations and Challenges Shaping Advanced Neurology Devices in an Era of Rapid Technological Evolution and Regulatory Shifts

The field of neurology devices stands at a pivotal juncture, where breakthroughs in technology and shifts in clinical practice are rapidly altering patient care protocols. As precision medicine gains momentum, device developers are integrating sophisticated sensors, artificial intelligence, and advanced materials to deliver tailored therapies that align with the unique neurophysiological profiles of patients. This drive toward personalization is fueled by a growing body of clinical evidence demonstrating improved outcomes and reduced adverse events.

Regulatory landscapes are also evolving, with agencies worldwide emphasizing post-market surveillance, cybersecurity standards, and streamlined pathways for digital therapeutics. At the same time, healthcare providers are under mounting pressure to demonstrate value, leading to increased collaboration between device manufacturers, payers, and clinical networks. Against this backdrop, a clear understanding of the interplay between innovation, regulation, and market access has never been more critical for stakeholders seeking to navigate complexity and capitalize on emerging opportunities.

How Emerging Technologies, Clinical Paradigm Shifts, and Cross-Disciplinary Integration Are Redefining Neurology Device Development and Patient Care Pathways

A wave of transformative shifts is reshaping the neurology devices landscape, driven by cross-disciplinary convergence and patient-centric design philosophies. Rapid advances in neuroimaging and intraoperative navigation have enabled minimally invasive interventions to become the new standard of care, reducing procedure times and accelerating recovery. In parallel, the proliferation of implantable neuromodulation systems is redefining therapeutic paradigms for conditions ranging from chronic pain to neurodegenerative disorders, with closed-loop feedback mechanisms enhancing efficacy and safety.

Meanwhile, the integration of machine learning algorithms into diagnostic platforms is unlocking predictive capabilities that were previously unattainable. This is complemented by the emergence of digital biomarkers, which harness wearable sensors and remote monitoring to capture rich datasets in real time. As industry players forge partnerships with technology innovators and academic centers, new business models are taking shape that prioritize outcome-based agreements and digital services alongside traditional capital equipment. Consequently, stakeholders must remain agile, anticipating how these converging trends will dictate the next frontier of clinical performance and commercial success.

Assessing the Aggregate Consequences of 2025 United States Tariffs on Neurology Device Supply Chains, Cost Structures, and Competitive Dynamics

The implementation of United States tariffs in 2025 has introduced significant headwinds for the neurology devices ecosystem, affecting every stage of the value chain. Manufacturers facing elevated duties on imported components have had to reassess sourcing strategies, with some relocating portions of production closer to end markets to mitigate cost impacts. This shift toward nearshoring has alleviated certain supply chain vulnerabilities, yet it has also necessitated substantial capital investment in domestic infrastructure.

On the demand side, hospitals and clinics are increasingly scrutinizing total cost of ownership, compelling device suppliers to justify price adjustments with demonstrable clinical and operational benefits. In response, vendors are accelerating innovation cycles, embedding connectivity features that support remote diagnostics and predictive maintenance to counterbalance tariff-induced price pressures. At the same time, collaborative consortia are emerging to share best practices in procurement and logistics, reinforcing resilience against future trade policy fluctuations. As a result, companies that proactively adapt their manufacturing footprint and value propositions are better positioned to sustain growth in this new trade environment.

Unveiling Key Segmentation Patterns Across Products, Applications, End Users, and Distribution Channels That Drive Strategic Decision Making in Neurology Devices

Critical segmentation analysis reveals nuanced drivers of adoption and investment, highlighting where clinical and commercial priorities intersect. When evaluating the product landscape, it becomes evident that technologies spanning CSF Management Devices-such as cerebral external drainage and cerebral shunts-and Interventional Neurology tools for aneurysm coiling and embolization, balloon angioplasty & stents, neurothromboectomy, and neurovascular catheters each present distinct innovation imperatives. Within aneurysm coiling and embolization, embolic coils, flow diversion devices, and liquid embolic reagents command attention for their role in reducing recurrence rates, while cerebral balloon angioplasty & stents strategies focus on optimizing device profiles for balloon occlusion, carotid artery stents, and filter devices. Equally, the evolution of neurothromboectomy highlights clot retrievers, snare devices, and suction aspiration systems, and the expanding realm of neurostimulation encompasses deep brain stimulation, gastric electric stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation. Finally, advances in neurosurgery devices like aneurysm clips, neuroendoscopes, stereotactic systems, and ultrasonic aspirators underscore the ongoing push toward precision and minimal invasiveness.

Similarly, application-based segmentation underscores the varying unmet needs across therapeutic areas. In chronic pain management, the emphasis is on long-term safety and patient comfort, whereas epilepsy & seizure disorders demand robust solutions for diagnosis & monitoring of epilepsy and seizure control devices. Treatment pathways for mental health disorders-including anxiety, depression, and schizophrenia-are evolving with neurostimulation and closed-loop monitoring, and multiple sclerosis strategies must accommodate both relapsing and progressive forms. Neurodegenerative disorder profiles span Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease, each requiring distinct device capabilities. Neurovascular disorders present acute intervention challenges, spinal cord injuries call for regenerative and assistive technologies, and stroke care differentiates between hemorrhagic stroke devices, ischemic stroke devices, and stroke rehabilitation devices. Traumatic brain injury remains a high-priority area for intracranial pressure management and neurorehabilitation.

On the end-user front, the ecosystem stretches from academic & research institutes and diagnostic centers to home care, hospitals, neurology clinics, and rehabilitation centers, each setting imposing unique training, reimbursement, and integration requirements. Distribution channels, whether offline or online, further shape go-to-market strategies, impacting everything from product demonstrations to post-sales support.

Analyzing Regional Opportunities and Challenges in the Americas, Europe Middle East Africa, and Asia Pacific That Shape Neurology Device Adoption Pathways

Regional dynamics play an outsized role in shaping the trajectory of neurology device markets, as diverse healthcare infrastructures, reimbursement frameworks, and patient demographics influence adoption rates. In the Americas, a well-established network of academic medical centers and a favorable regulatory climate for digital therapeutics support rapid uptake of advanced monitoring and neuromodulation systems. Yet cost containment pressures and shifts toward value-based care models are driving heightened scrutiny of long-term clinical benefits.

Europe Middle East Africa embodies a mosaic of markets where regulatory harmonization under evolving directives intersects with national payer negotiations. This environment creates both barriers and opportunities for device innovators, particularly those leveraging real-world evidence to substantiate outcomes. Growing investments in neurovascular centers of excellence are enhancing the profile of interventional neurology and stroke rehabilitation technologies.

In Asia Pacific, dynamic growth is underpinned by expanding healthcare budgets, rising incidence of neurological disorders, and government initiatives to bolster domestic manufacturing capabilities. Local partnerships and licensing agreements have become essential pathways for global manufacturers seeking to navigate diverse regulatory landscapes and accelerate market entry. Consequently, stakeholders must adopt differentiated regional strategies that account for local standards, reimbursement pathways, and clinician training requirements.

Profiling Leading Players and Innovators to Highlight Strategic Collaborations, Innovation Pathways, and Competitive Differentiators in Neurology Devices

Leading players and rising innovators are establishing new benchmarks through strategic collaborations, targeted research and development investments, and the creation of integrated care models. Established firms are deepening partnerships with academic centers to co-develop next-generation neurostimulation platforms that incorporate advanced sensing and adaptive algorithms. Concurrently, venture-backed startups are pioneering bioelectronics and soft robotics, demonstrating proof-of-concept successes that are attracting licensing and acquisition interest.

Partnerships between device manufacturers and digital health providers are expanding the scope of remote patient management, with cross-industry alliances enabling the incorporation of cloud-based analytics and telemedicine workflows. Patent portfolios and regulatory approvals serve as key differentiators, and companies that maintain a balanced mix of incremental enhancements and disruptive breakthroughs are consistently outperforming peers in clinical acceptance. As M&A activity accelerates in areas such as minimally invasive interventional neurology and closed-loop neuromodulation, market leadership hinges on the ability to integrate complementary assets and scale solutions across global markets.

Strategic Roadmap for Industry Leaders to Navigate Regulatory Complexities, Capitalize on Technological Advances, and Strengthen Position in Neurology Devices

Industry leaders must adopt a forward-looking strategy that aligns R&D priorities with evolving clinical and regulatory paradigms. Companies should prioritize the development of platform technologies capable of supporting multiple indications, thereby maximizing return on investment and facilitating cross-functional synergies. Investing in robust data analytics and remote monitoring capabilities will enhance real-world evidence generation, which is increasingly vital for securing favorable reimbursement and payer contracts.

At the same time, regional supply chain diversification and nearshoring initiatives should be advanced to buffer against future trade policy disruptions. Engaging early with regulatory agencies on digital health guidelines and post-market surveillance expectations can streamline approval pathways and minimize time to market. Finally, forging collaborative ecosystems with healthcare providers, technology firms, and patient advocacy groups will accelerate adoption and ensure that product roadmaps remain closely aligned with unmet clinical needs.

Comprehensive Research Approach Combining Primary Interviews, Secondary Data Analysis, and Statistical Validation to Ensure Robust Insights in Neurology Devices

This research employs a multi-phased approach to ensure the integrity and relevance of insights. Primary data collection involved structured interviews with key opinion leaders, including neurologists, interventional radiologists, and device engineers, to capture firsthand perspectives on unmet needs and innovation bottlenecks. Secondary research sources encompassed regulatory databases, clinical trial registries, and peer-reviewed literature to contextualize product pipelines and approval trends.

Quantitative analysis was conducted using a rigorous data triangulation framework that reconciled manufacturer disclosures, hospital procurement records, and publicly available financial reports. Statistical validation techniques were applied to identify significant trends and correlations. An expert advisory board reviewed intermediate findings to refine assumptions and interpret emerging themes, thereby ensuring that the final deliverables reflect both empirical evidence and real-world clinical practice.

Synthesizing Key Findings and Strategic Imperatives to Illuminate Future Directions and Investment Opportunities in the Neurology Devices Landscape

The neurology devices landscape is defined by rapid technological advancement, shifting reimbursement models, and increasingly complex regulatory frameworks. Through this analysis, it is clear that success will favor organizations that integrate digital intelligence, deepen strategic partnerships, and maintain agile manufacturing footprints. Personalization of therapies through closed-loop neuromodulation and minimally invasive interventions is set to drive the next wave of clinical breakthroughs.

Looking forward, industry players that invest in scalable platform technologies and robust evidence generation will be best positioned to capture new opportunities. Cross-border collaboration and adaptive regulatory engagement will accelerate commercialization, ultimately improving patient outcomes and unlocking sustainable growth. The insights presented here form a blueprint for navigating uncertainty and charting a course toward continued innovation in neurology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growth and integration of AI-enabled portable EEG wearables for continuous home epilepsy monitoring
  • 5.2. Advances in closed-loop deep brain stimulation devices offering adaptive therapy for Parkinson's disease management
  • 5.3. Rising adoption of noninvasive transcranial magnetic stimulation devices for treatment-resistant major depressive disorder
  • 5.4. Emergence of implantable wireless neurostimulation systems with smartphone connectivity for chronic neuropathic pain relief
  • 5.5. Development of high-density intracortical electrode arrays enabling real-time brain-computer interface control in paralysis rehabilitation
  • 5.6. Expansion of miniaturized wearable near-infrared spectroscopy devices for noninvasive monitoring in stroke recovery programs

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Neurology Devices Market, by Product

  • 8.1. Introduction
  • 8.2. CSF Management Devices
    • 8.2.1. Cerebral External Drainage
    • 8.2.2. Cerebral Shunts
  • 8.3. Interventional Neurology
    • 8.3.1. Aneurysm Coiling and Embolization
      • 8.3.1.1. Embolic Coils
      • 8.3.1.2. Flow Diversion Devices
      • 8.3.1.3. Liquid Embolic Reagents
    • 8.3.2. Cerebral Balloon Angioplasty & Stents
      • 8.3.2.1. Balloon Occlusion Devices
      • 8.3.2.2. Carotid Artery Stents
      • 8.3.2.3. Filter Devices
    • 8.3.3. Neurothromobectomy
      • 8.3.3.1. Clot Retrievers
      • 8.3.3.2. Snare Devices
      • 8.3.3.3. Suction Aspiration Devices
    • 8.3.4. Neurovascular Catheters
  • 8.4. Neurostimulation
    • 8.4.1. Deep Brain Stimulation
    • 8.4.2. Gastric Electric Stimulation
    • 8.4.3. Sacral Nerve Stimulation
    • 8.4.4. Spinal Cord Stimulation
    • 8.4.5. Vagus Nerve Stimulation
  • 8.5. Neurosurgery Devices
    • 8.5.1. Aneurysm Clips
    • 8.5.2. Neuroendoscopes
    • 8.5.3. Stereotactic Systems
    • 8.5.4. Ultrasonic Aspirators

9. Neurology Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Chronic Pain
  • 9.3. Epilepsy & Seizure Disorders
    • 9.3.1. Diagnosis & Monitoring of Epilepsy
    • 9.3.2. Seizure Control Devices
  • 9.4. Mental Health Disorders
    • 9.4.1. Anxiety
    • 9.4.2. Depression
    • 9.4.3. Schizophrenia
  • 9.5. Multiple Sclerosis (MS)
  • 9.6. Neurodegenerative Disorders
    • 9.6.1. Alzheimer's Disease
    • 9.6.2. Amyotrophic Lateral Sclerosis (ALS)
    • 9.6.3. Huntington's Disease
    • 9.6.4. Parkinson's Disease
  • 9.7. Neurovascular Disorders
  • 9.8. Spinal Cord Injuries
  • 9.9. Stroke
    • 9.9.1. Hemorrhagic Stroke Devices
    • 9.9.2. Ischemic Stroke Devices
    • 9.9.3. Stroke Rehabilitation Devices
  • 9.10. Traumatic Brain Injury (TBI)

10. Neurology Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Diagnostic Centers
  • 10.4. Home Care
  • 10.5. Hospitals
  • 10.6. Neurology Clinics
  • 10.7. Rehabilitation Centers

11. Neurology Devices Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Americas Neurology Devices Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Neurology Devices Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Neurology Devices Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Acandis GmbH
    • 15.3.3. B. Braun SE
    • 15.3.4. Boston Scientific Corporation
    • 15.3.5. Esaote SpA
    • 15.3.6. GE HealthCare Technologies, Inc.
    • 15.3.7. Integra LifeSciences Holdings
    • 15.3.8. Koninklijke Philips N.V.
    • 15.3.9. Masimo Corporation
    • 15.3.10. Medtronic PLC
    • 15.3.11. MicroPort Scientific Corporation
    • 15.3.12. Natus Medical Inc.
    • 15.3.13. Nihon Kohden Corporation
    • 15.3.14. Penumbra Inc.
    • 15.3.15. Rapid Medical Ltd.
    • 15.3.16. Siemens Healthcare GmbH
    • 15.3.17. Stryker Corporation
    • 15.3.18. Terumo Corporation

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. NEUROLOGY DEVICES MARKET: RESEARCHAI
  • FIGURE 24. NEUROLOGY DEVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 25. NEUROLOGY DEVICES MARKET: RESEARCHCONTACTS
  • FIGURE 26. NEUROLOGY DEVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 173. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 175. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 177. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 179. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 183. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 225. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 226. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 227. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 228. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 229. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 230. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 231. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 233. CANADA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. CANADA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 237. CANADA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 239. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 241. CANADA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 243. CANADA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. CANADA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 257. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 259. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 261. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 263. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 265. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 266. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 267. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 268. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 269. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 270. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 271. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 272. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 273. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 275. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 277. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 279. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 281. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 283. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 285. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 287. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 288. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 289. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 290. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 291. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 293. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 295. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 296. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 297. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 298. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 299. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 300. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 301. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 302. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 303. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 307. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 308. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 309. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 310. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 311. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 314. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 315. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 316. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 317. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 318. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 319. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 321. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (US